Poland· PL-100375984
Bexon
A a11db01, n07xb52 product containing thiamini hydrochloridum + pyridoxini hydrochloridum + cyanocobalaminum, registered in Poland by Aflofarm Farmacja Polska Sp. z o.o..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Thiamini hydrochloridum + Pyridoxini hydrochloridum + Cyanocobalaminum
- Manufacturer
- Aflofarm Farmacja Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- A11DB01, N07XB52
- ATC class
- A11DB01, N07XB52
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991307158
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fe55eb98-e296-4a2c-bd34-ff3ec8bc36b7 GET /v1/drugs/fe55eb98-e296-4a2c-bd34-ff3ec8bc36b7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "(50 mg + 50 mg + 0,5 mg)/ml",
"packaging": "05909991307158 ¦ Rp ¦ 119193\n5 amp. 2 ml",
"substance": "Thiamini hydrochloridum 50 mg/ml + Pyridoxini hydrochloridum 50 mg/ml + Cyanocobalaminum 0,5 mg/ml",
"common_name": "Thiamini hydrochloridum + Pyridoxini hydrochloridum + Cyanocobalaminum",
"pl_product_id": "100375984",
"pozwolenie_nr": "23610",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about thiamini hydrochloridum + pyridoxini hydrochloridum + cyanocobalaminum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.